We’re launching Lyria 3.5 in Google Flow Music, with advances across musicality, lyrics, vocals, and creative control
deepmind.google·6d ago
AI Engineering
OpenAI Blog·Aug 7·5 min read
How Amgen uses GPT-5
TL;DR
Amgen faced challenges in drug discovery and development, particularly in analyzing vast amounts of biomedical data. They implemented GPT-5, a state-of-the-art language model, to enhance data interpretation and streamline research processes.
✦ Why It Matters
Engineers and researchers can leverage AI models like GPT-5 to enhance data analysis in their own projects.
Key Takeaways
- Explore AI models for data analysis in research.
- Consider training models on domain-specific texts.
- Measure efficiency improvements in research timelines.
- Collaborate with AI experts to implement solutions.
Full Summary
In the competitive field of biotechnology, Amgen sought to improve its drug discovery process, which often involves sifting through extensive biomedical literature and data. By integrating GPT-5, a powerful language model developed by OpenAI, Amgen aimed to automate and enhance the analysis of complex datasets.
The methodology involved training GPT-5 on specific biomedical texts to tailor its responses to the nuances of drug development. Initial findings indicated that researchers could identify promising drug candidates up to 30% faster than traditional methods.
Additionally, the model facilitated more accurate predictions regarding drug interactions and efficacy. These advancements not only reduced the time required for research but also improved the quality of insights generated.
For engineers and researchers, this demonstrates the potential of AI in transforming data-heavy processes in life sciences.